SQM Reports Strong Q4 & Full-Year 2025 Earnings, Lithium Business Sees Record Volumes and Positive Outlook
Summary
CHEMICAL & MINING CO OF CHILE INC reported a significant turnaround in 2025, swinging from a net loss to a profit, driven by strong fourth-quarter performance and record lithium sales volumes with an optimistic market outlook.
Key Events
-
Full-Year Profit Turnaround
The company swung from a net loss of US$(404.4) million in 2024 to a net income of US$588.1 million for the twelve months ended December 31, 2025.
-
Strong Q4 Performance
Net income for the fourth quarter of 2025 increased 53.0% to US$183.8 million, with revenues up 23.3% to US$1,323.9 million compared to the same period last year.
-
Record Lithium Volumes & Positive Outlook
The lithium and derivatives segment achieved record-high sales volumes in Q4 2025, with average realized prices increasing nearly 14% quarter-over-quarter. The CEO anticipates approximately 25% growth in the lithium market for 2026, driven by EVs and energy storage systems.
-
Iodine Segment Strength
The Iodine and Derivatives division delivered solid performance, contributing 42% of SQM's total gross profit for 2025, with record iodine prices observed in Q4 amid tight supply and strong demand.
Analysis
The company's full-year 2025 results show a substantial improvement, moving from a net loss in 2024 to a significant net income, primarily fueled by robust performance in the fourth quarter. The lithium and derivatives segment was a key driver, achieving record sales volumes and experiencing a favorable pricing environment, which is expected to continue into 2026 due to strong demand from electric vehicles and energy storage systems. This positive earnings report, especially the strong Q4 growth and optimistic guidance for its core lithium business, provides a strong signal of operational recovery and market strength for SQM.
At the time of this filing, SQM was trading at $75.09 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $21.1B. The 52-week trading range was $29.36 to $86.13. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.